Skip to main navigation
Skip to search
Skip to main content
Northwestern Scholars Home
Help & FAQ
Home
Experts
Organizations
Research Output
Grants
Core Facilities
Research Data
Search by expertise, name or affiliation
Who is best benefited by radical prostatectomy?
R. B. Nadler, G. L. Andriole
*
*
Corresponding author for this work
Urology
Research output
:
Contribution to journal
›
Article
›
peer-review
7
Scopus citations
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Who is best benefited by radical prostatectomy?'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Prostate Cancer
100%
Radical Prostatectomy
100%
Life Expectancy
40%
Progressive Disease
20%
Clinical Parameters
20%
Young Men
20%
Organ-confined
20%
Pathological Stage
20%
Serum PSA
20%
Low Stage
20%
Medicine and Dentistry
Prostate Cancer
100%
Prostatectomy
100%
Life Expectancy
40%
Progressive Disease
20%
Nursing and Health Professions
Prostate Cancer
100%
Prostatectomy
100%
Life Expectancy
40%
Disease
20%
Pharmacology, Toxicology and Pharmaceutical Science
Prostate Cancer
100%
Life Expectancy
40%
Disease
20%